Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Larsen, Jeppe Madura ^a   Steen Jensen, Daniel Bisgaard ^a   Laursen, Janne Marie ^a   Søndergaard, Jonas Nørskov ^a   Musavian, Hanieh Sadat ^a   Butt, Tariq Mahmood ^a   Brix, Susanne ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 23; AUTACOID; CYTOKINE;

ACTINOMYCES; AIRWAY MICROFLORA; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; CELL ACTIVATION; CELL MATURATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMENSAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; MICROFLORA; MONOCYTE; MORAXELLA; NONHUMAN; PREVOTELLA; VEILLONELLA; BACTERIUM; BIOSYNTHESIS; CELL DIFFERENTIATION; DONOR; GENETICS; IMMUNOLOGY; LUNG; METAGENOME; MICROBIOLOGY; PATHOLOGY; PHYLOGENY; PRINCIPAL COMPONENT ANALYSIS; SPECIES DIFFERENCE;

BACTERIA; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; HAEMOPHILUS; HUMANS; INFLAMMATION MEDIATORS; LUNG; METAGENOME; PHYLOGENY; PREVOTELLA; PRINCIPAL COMPONENT ANALYSIS; SPECIES SPECIFICITY; TISSUE DONORS;

EID: 84857410545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031976     Document Type: Article

References (63)

1. Sonnenburg JL, Angenent LT, Gordon JI, (2004) Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nature immunology 5: 569-73.
2. Medini D, Serruto D, Parkhill J, Relman DA, Donati C, et al. (2008) Microbiology in the post-genomic era. Nature reviews. Microbiology 6: 419-30.
3. Grice EA, Segre JA, (2011) The skin microbiome. Nature reviews. Microbiology 9: 244-53.
4. Kahn FW, Jones JM, (1987) Diagnosing bacterial respiratory infection by bronchoalveolar lavage. The Journal of infectious diseases 155: 862-9.
5. Baughman R, Thorpe J, Staneck J, Rashkin M, Frame P, (1987) Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest 91: 233-236.
6. Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL, (1987) Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. The Journal of infectious diseases 155: 855-61.
7. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, et al. (2011) Analysis of the lung microbiome in the "healthy" smoker and in COPD. PloS one 6: e16384.
8. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, et al. (2007) Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proceedings of the National Academy of Sciences of the United States of America 104: 20529-33.
9. Charlson ES, Chen J, Custers-Allen R, Bittinger K, Li H, et al. (2010) Disordered microbial communities in the upper respiratory tract of cigarette smokers. PloS one 5: e15216.
10. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, et al. (2010) Disordered microbial communities in asthmatic airways. PloS one 5: e8578.
11. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, et al. (2011) Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. The Journal of allergy and clinical immunology 127: 372-381.e1-3.
12. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. (2000) Immunobiology of dendritic cells. Annual review of immunology 18: 767-811.
13. Sallusto F, Lanzavecchia A, (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. The Journal of experimental medicine 179: 1109-18.
14. Kapsenberg ML, (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nature reviews. Immunology 3: 984-93.
15. Pittman M, (1931) Variation and type specificity in the bacterial species Hemophilus influenzae. The Journal of experimental medicine 53: 471-92.
16. Geme JWS, (2002) Molecular and cellular determinants of non-typeable Haemophilus influenzae adherence and invasion. Cellular Microbiology 4: 191-200.
17. Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A, (2002) Moraxella catarrhalis: from emerging to established pathogen. Clinical microbiology reviews 15: 125-44.
18. Zhou LJ, Tedder TF, (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 93: 2588-92.
19. Madura Larsen J, Benn CS, Fillie Y, van der Kleij D, Aaby P, et al. (2007) BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology 121: 276-82.
20. Hunter CA, (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nature reviews. Immunology 5: 521-31.
21. Dubin PJ, Kolls JK, (2008) Th17 cytokines and mucosal immunity. Immunological reviews 226: 160-71.
22. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annual review of immunology 19: 683-765.
23. Kelly D, Conway S, Aminov R, (2005) Commensal gut bacteria: mechanisms of immune modulation. Trends in immunology 26: 326-33.
24. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI, (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915-20.
25. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-11.
26. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, et al. (2006) Specificities of the fecal microbiota in inflammatory bowel disease. Inflammatory bowel diseases 12: 106-11.
27. Sheil B, Shanahan F, O'Mahony L, (2007) Probiotic effects on inflammatory bowel disease. The Journal of nutrition 137: 819S-24S.
28. Sartor RB, (2005) Probiotic therapy of intestinal inflammation and infections. Current opinion in gastroenterology 21: 44-50.
29. Fink J, Mathaba LT, Stewart GA, Graham PT, Steer JH, et al. (2006) Moraxella catarrhalis stimulates the release of proinflammatory cytokines and prostaglandin E from human respiratory epithelial cells and monocyte-derived macrophages. FEMS immunology and medical microbiology 46: 198-208.
30. Galdiero M, Galdiero M, Finamore E, Rossano F, Gambuzza M, et al. (2004) Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. Infection and immunity 72: 1204-9.
31. Berenson CS, Murphy TF, Wrona CT, Sethi S, (2005) Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infection and immunity 73: 2728-35.
32. Berenson CS, Wrona CT, Grove LJ, Maloney J, Garlipp MA, et al. (2006) Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. American journal of respiratory and critical care medicine 174: 31-40.
33. King PT, Hutchinson PE, Johnson PD, Holmes PW, Freezer NJ, et al. (2003) Adaptive immunity to nontypeable Haemophilus influenzae. American journal of respiratory and critical care medicine 167: 587-92.
34. Knobloch J, Schild K, Jungck D, Urban K, Müller K, et al. (2011) The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD. American journal of respiratory and critical care medicine 183: 204-14.
35. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, et al. (2003) Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. Journal of immunology 171: 4984-9.
36. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J, (2007) Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 109: 1574-83.
37. Miller SI, Ernst RK, Bader MW, (2005) LPS, TLR4 and infectious disease diversity. Nature reviews. Microbiology 3: 36-46.
38. Lebeer S, Vanderleyden J, Keersmaecker SCJDe, (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nature reviews. Microbiology 8: 171-84.
39. Caroff M, Karibian D, (2003) Structure of bacterial lipopolysaccharides. Carbohydrate research 338: 2431-47.
40. Caroff M, Karibian D, Cavaillon JM, Haeffner-Cavaillon N, (2002) Structural and functional analyses of bacterial lipopolysaccharides. Microbes and infection 4: 915-26.
41. Alhawi M, Stewart J, Erridge C, Patrick S, Poxton IR, (2009) Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. Journal of medical microbiology 58: 1015-22.
42. Schweda EKH, Twelkmeyer B, Li J, (2008) Profiling structural elements of short-chain lipopolysaccharide of non-typeable Haemophilus influenzae. Innate immunity 14: 199-211.
43. Masoud H, Perry MB, Richards JC, (1994) Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. European journal of biochemistry/FEBS 220: 209-16.
44. Hashimoto M, Asai Y, Tamai R, Jinno T, Umatani K, et al. (2003) Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide. FEBS letters 543: 98-102.
45. Matera G, Muto V, Vinci M, Zicca E, Abdollahi-Roodsaz S, et al. (2009) Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clinical and vaccine immunology 16: 1804-9.
46. de Heer HJ, Hammad H, Kool M, Lambrecht BN, (2005) Dendritic cell subsets and immune regulation in the lung. Seminars in immunology 17: 295-303.
47. Somerville JE, Cassiano L, Bainbridge B, Cunningham MD, Darveau RP, (1996) A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. The Journal of clinical investigation 97: 359-65. A.
48. Coats SR, Reife RA, Bainbridge BW, Pham TT-T, Darveau RP, (2003) Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infection and immunity 71: 6799-807.
49. Coats SR, Pham T-TT, Bainbridge BW, Reife RA, Darveau RP, (2005) MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex. Journal of immunology 175: 4490-8.
50. Goriely S, Molle C, Nguyen M, Albarani V, Haddou NO, et al. (2006) Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 107: 1078-84.
51. Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, et al. (2008) Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. The Journal of experimental medicine 205: 1447-61.
52. Kastelein RA, Hunter CA, Cua DJ, (2007) Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annual review of immunology 25: 221-42.
53. Lu Y-J, Gross J, Bogaert D, Finn A, Bagrade L, et al. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS pathogens 4: e1000159.
54. Zhang Z, Clarke TB, Weiser JN, (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. The Journal of clinical investigation 119: 1899-909.
55. Murphy TF, Sethi S, Niederman MS, (2000) The role of bacteria in exacerbations of COPD. A constructive view. Chest 118: 204-9.
56. Sethi S, Evans N, Grant BJB, Murphy TF, (2002) New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. The New England journal of medicine 347: 465-71.
57. Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, et al. (2007) Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 176: 356-61.
58. Bisgaard H, Hermansen MN, Bønnelykke K, Stokholm J, Baty F, et al. (2010) Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ 341: c4978.
59. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, et al. (2007) Childhood asthma after bacterial colonization of the airway in neonates. The New England journal of medicine 357: 1487-95.
60. Gibson PG, Simpson JL, Saltos N, (2001) Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119: 1329-36.
61. Haldar P, Pavord ID, (2007) Noneosinophilic asthma: a distinct clinical and pathologic phenotype. The Journal of allergy and clinical immunology 119: 1043-52; quiz 1053-4.
62. Moghaddam SJ, Clement CG, Garza MMDe la, Zou X, Travis EL, et al. (2008) Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. American journal of respiratory cell and molecular biology 38: 629-38.
63. Gaschler GJ, Skrtic M, Zavitz CCJ, Lindahl M, Onnervik P-O, et al. (2009) Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. American journal of respiratory and critical care medicine 179: 666-75.